Lithium, considered the standard therapy for bipolar disorder for at least 50 years, has been found to increase the amount of gray matter in the brains of patients with the illness. Neuroscientists at the University of California, Los Angeles, used high-resolution, three-dimensional magnetic resonance imaging (MRI) to map the entire surface of the brain. They [...]
Seroquel medication is an approved medicine for bipolar disorder and schizophrenia medication. However, Seroquel drug is not approved for treatment of patients with dementia-related psychosis. Since its approval in 1997, SEROQUEL has had over 8 million patient exposures worldwide. The results of a safety investigation, which assessed the risk of cerebrovascular adverse events (CVAEs) in [...]
The following safety information is necessary for those who prescribes or is prescribed to take generic Risperdal as antipsychotic medication. First of all, Risperdal (Risperidone) is not approved for the treatment of patients with Dementia-Related Psychosis. Such elderly patients treated with atypical antipsychotic drugs are at an increased risk of death. Second, Risperdal medication can [...]
ABILIFY (Aripiprazole) drug was developed by two companies: Otsuka Pharmaceutical Co., Ltd and Bristol-Myers Squibb Company. In 2004 Abilify medicine was approved in for treating schizophrenia disease and in 2008 it was ratified as medicine for bipolar disorder. It has been known today that the U.S. Food and Drug Administration (FDA) has accepted for filing [...]
Professor Eduard Vieta, Clinical Institute of Neuroscience, University of Barcelona, Spain suggests that bipolar disorder is considered to be a chronic, lifelong illness. Patients can become depressed or manic. And it is generally agreed that maintenance therapy is important and can give long-term relief from the relapses. The data from new investigation of Seroquel medication [...]
Risperdal drug (Risperidone) is an oral prescription medication that has been approved in the UK for the treatment of mania in bipolar disorder, also known as manic-depression. It causes periods of extreme depression and mania and leads to unusual shifts in a person’s energy, mood and ability to function. This chronic illness needs to be [...]
Abilify drug was generally approved in 2004 for treating schizophrenia disease and this medicine was supposed to be used in treating bipolar disorder. Indeed, on April 8, 2008, the European Commission allowed Abilify medication (Aripiprazole) to be marketed for patients with Bipolar I Disorder. Such kind of disease as Bipolar I Disorder contains one or [...]
